Just about all prostate cancers are first identified by testing with a blood test for prostate-specific antigen (PSA) and in some cases a digital rectal examination (DRE). Early prostate cancers typically do not create any symptoms but often more serious cancers are first detected due to the signs they trigger. If prostate cancer is reported based on symptoms or screening tests, other tests are important to be certain. People visiting their family doctor, may be sent to a urologist, a specialist who examines urinary tract and genital cancers, including prostate cancers.
Get Latest Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/1580
Prostate cancer can be reliably detected only with a prostate biopsy. Doctors who do prostate biopsies also depend on transrectal ultrasound which uses sound waves to produce black and white pictures of the prostate, to determine where and how to take samples. Yet certain areas with cancer can bypass normal ultrasonics. Several newer methods are available for diagnosing prostate cancer. The surgical procedures used for treating prostate cancer are continuously evolving by physicians. The goal is to eliminate any cancer while minimizing the risk of infections and adverse effects from the operation.
Prostate Cancer diagnosis and therapy market is forecast to record the growth at a CAGR of 5.1 percent to touch US$18,417.72 Million mark by 2025. Researchers are exploring modern methods of treatment for early-stage prostate cancer. Such new therapies may either be used as the first type of therapy or after inadequate radiotherapy. Many researchers have examined the potential benefits of different nutrients in helping with prostate cancer care, but none have demonstrated a definite advantage so far. Some of the compounds under study include green tea, pomegranate, broccoli, flaxseed, turmeric, and soy extracts.
The market for prostate cancer diagnosis and therapy market is segmented into component, type, and end user. The worldwide market is bifurcated by type into small-cell carcinoma, prostatic adenocarcinoma, and others. The global market is further segmented into analysers, reagents, and consumables on the basis of products. The global market for prostate cancer diagnosis and treatment is classified into therapy and diagnosis, depending on the components. Additionally, the therapy segment is further divided into hormone therapy, radiotherapy, radiation, and immunotherapy. The market segment known as hormonal therapy is then categorized into LHRH analogs, anti-androgens, and LHRH antagonists. On the basis of end users, the global market for prostate cancer diagnosis and therapy is further segmented into hospitals and clinics, specialty centers, and others.
The region-based global demand for prostate cancer diagnosis and therapy is divided into Europe, Americas, Asia-Pacific and Middle East and Africa. The America reported for the largest market share in 2018, and the regional markets in North America and South America are expected to continue the dominance over the forecast period due to high occurrence levels of prostate cancer in the country, increasing population of elderly people, and a rise in prostate cancer care. The European market is expected to witness second largest growth in the prostate cancer diagnosis and therapy market. Asia-Pacific and the Middle East and Africa regions will follow the lead, as predicted by analysts.
In a Phase 3 trial, AstraZeneca and associate Merck & Co. announced their drug Lynparza helped prolong the lifespan of patients with prostate cancer of which the tumors had a particular genetic mutation relative to conventional hormone therapy. The two organizations didn’t reveal information. But the findings add to a wealth of evidence indicating an potential position for a fairly new drug class called PARP inhibitors in prostate cancer, which is already licensed as breast and ovarian breast cancer treatments.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.